{"schema_version":"secwatch.filing_event.v1","accession":"0001564590-22-001365","form_type":"8-K","ticker":"TRVI","cik":"0001563880","company_name":"Trevi Therapeutics, Inc.","filed_at":"2022-01-14T23:59:59+00:00","discovered_at":"2026-05-14T18:04:07.001984+00:00","generated_at":"2026-06-27T17:55:33.073690+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Trevi Therapeutics receives Nasdaq bid price deficiency notice; has until July 11, 2022 to regain compliance","bullets":["Received deficiency letter from Nasdaq on Jan 10, 2022; bid price closed below $1.00 for 30 consecutive business days.","Company has 180 calendar days (until July 11, 2022) to regain compliance by closing at $1.00+ for 10 consecutive days.","If not compliant, may transfer to Nasdaq Capital Market for an additional 180-day compliance period, subject to other standards.","May consider a reverse stock split or other measures to cure; no assurance of regaining compliance."],"urls":{"canonical":"https://secwatch.observer/filing/0001564590-22-001365","json":"https://secwatch.observer/filing/0001564590-22-001365.json","markdown":"https://secwatch.observer/filing/0001564590-22-001365.md","text":"https://secwatch.observer/filing/0001564590-22-001365.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1563880/000156459022001365/0001564590-22-001365-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1563880/000156459022001365/trvi-8k_20220110.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T17:55:33.073690+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}